Self-reported hepatitis C virus antibody status and risk behavior in young injectors
about
Analysis of duration of risk behaviour for key populations: a literature reviewImproving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load CriteriaCost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersInfectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target?Ending hepatitis C in the United States: the role of screening.Use of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort studyHIV and HCV discordant injecting partners and their association to drug equipment sharingAccess to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care.Exploring sex differences in drug use, health and service use characteristics among young urban crack users in BrazilPrevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities.Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi'an, ChinaAssociations between prescription opioid injection and Hepatitis C virus among young injection drug users.High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia.Community-based HCV screening: knowledge and attitudes in a high risk urban populationSexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling intervention.Hepatitis C surveillance among youth and young adults in New York City, 2009-2013.Managing chronic hepatitis C in primary-care settings: more than antiviral therapyHepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, ChinaHepatitis C testing and status among opioid substitution treatment clients in New South WalesSubstance use and hepatitis C: an ecological momentary assessment study.Cost-effectiveness and population outcomes of general population screening for hepatitis C.New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison.Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).Knowledge of viral hepatitis among Puerto Rican adults: implications for prevention.Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.The Impact of Enhanced Screening and Treatment on Hepatitis C in the United StatesHealthcare disparities in Asians and Pacific Islanders with hepatocellular cancer.On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange.Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenanceA simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users.
P2860
Q27011344-A05EB601-A741-4DE3-8FF1-7FF21AED2B2DQ27489594-AD5FFA2A-6A57-46D8-A7E0-A8628F43EDB7Q28483820-9A7AA19B-220E-45C9-8095-F23563DCF5F6Q30395708-C0DA968B-6683-43BD-8BD4-26E969849FF4Q31168171-ED5D1E55-9417-4A32-943F-7D3B994F83B4Q33590896-0BEC7D61-BB7B-4FFD-8649-F00792EED635Q33834953-E2F60023-ECD5-44B1-831A-C6A243C4A349Q33834958-FB7D8702-5CDC-48B5-B387-A85D8B5F17ADQ33858322-D0AC985E-F8A7-4244-AEB0-B933CC827FCBQ33862919-0D38417A-709A-437B-87B1-94B58945119DQ33884145-40EEA971-81AF-40DA-B77D-EB724900506EQ34088229-7110D425-CC71-4675-9A86-930347739349Q34088245-8AFA5B0F-39AD-4A00-B8D7-CEC8D5CCE695Q34322384-911CF549-CDB1-46E8-A7C5-EBCF692095A4Q34570190-C9327026-6E3D-4394-B596-49139DBBB666Q34620876-4CE85A51-A135-4DB8-8C8B-B6946470F55EQ34677180-19077AD8-FE4B-49C3-94C7-F1E1967AF79CQ34864661-47D204B4-3D32-491F-823D-49899AAE2557Q34971493-675D7D84-5636-491E-BCD3-7FA028FBBE0DQ34980145-A48716DD-0B6C-418F-91F4-CB7FACA90479Q35089934-684B03CF-B00F-4BBD-A596-558B7BBB82A8Q35199192-F80EB833-685F-4A55-9408-C4ADA24F80CEQ35543351-5F7DDE53-916D-4700-BF7E-CBFACAFF8A0CQ35696990-42D77B4A-37A6-4161-AA19-07944189F89BQ35773225-63DBBA1D-9BBF-48BD-B8C4-2518C58BE60FQ35988374-F94F2D10-1DF6-469C-854B-D9B7DBFECC5EQ36073120-19BB42D2-434E-4113-A282-ED3BDC877B9CQ36115516-62020924-8A2E-452F-8C9D-BB0F2155C6D0Q36127059-7B3539C7-1CD0-4C27-B93A-6FFCC621360CQ36144776-E94EBD39-B81C-45BC-AEA5-1C70885BC5AAQ36296534-85784992-445F-4D42-A441-8DFA4550C97AQ36425701-3871A954-C770-4A99-95EC-BE9DCD6EF712Q36446133-8685263E-07A6-4C79-B40E-3DBE2CDD97AAQ36472500-D22986F4-9989-4C97-9839-2DA6CAAD0592Q36646287-B53573E0-3AC3-4EEF-9156-7BD6A42DCAE6Q36663249-96E1484E-CFC0-47DE-8BC3-9FAE1C353D96Q36725091-C5DFCBB5-7E92-46D9-8893-D0BF3D8B3D99Q36858894-9F703EF0-96DE-45F4-ACEC-E82A7F5E1A04Q37011167-35CB6D7B-020F-4911-9C42-0D607741885AQ37015619-F00EF46C-9ED6-4C26-AA3F-AF73D23E3652
P2860
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@ast
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@en
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@nl
type
label
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@ast
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@en
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@nl
prefLabel
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@ast
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@en
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@nl
P2093
P2860
P1476
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
@en
P2093
Farzana Kapadia
Hanne Thiede
Jennifer Campbell
Lawrence Ouellet
Richard S Garfein
Sharon Hudson
Steffanie Strathdee
P2860
P356
10.1177/003335490612100611
P407
P50
P577
2006-01-01T00:00:00Z